Mutual Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $304K | Sell |
|
|||||
|
2025
Q2 | $500K | Buy |
|
|||||
|
2025
Q1 | $505K | Sell |
|
|||||
|
2024
Q4 | $676K | Sell |
|
|||||
|
2024
Q3 | $1.09M | Buy |
|
|||||
|
2024
Q2 | $1.04M | Buy |
|
|||||
|
2024
Q1 | $920K | Sell |
|
|||||
|
2023
Q4 | $1.49M | Sell |
|
|||||
|
2023
Q3 | $1.69M | Buy |
|
|||||
|
2023
Q2 | $583K | Sell |
|
|||||
|
2023
Q1 | $710K | Buy |
|
|||||
|
2022
Q4 | $574K | Buy |
|
|||||
|
2022
Q3 | $546K | Buy |
|
|||||
|
2022
Q2 | $420K | Buy |
|
|||||
|
2022
Q1 | $483K | Buy |
|
|||||
|
2021
Q4 | $432K | Buy |
|
|||||
|
2021
Q3 | $386K | Sell |
|
|||||
|
2021
Q2 | $370K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $702K | Buy |
|